Navigation Links
New regulatory circuit identified for aggressive, malignant brain tumor
Date:4/7/2008

Research using a newly developed algorithm has significantly advanced understanding of the molecular events associated with the most common primary brain tumor in adults, human glioblastoma (GBM). The research, published by Cell Press in the April issue of the journal Cancer Cell, validates known genetic aberrations and identifies events not previously linked with GBM, thereby elucidating new directions for potential therapeutic strategies.

GBM is a devastating neurological cancer that is characterized by widespread invasion, robust angiogenesis and a stubborn resistance to conventional and targeted treatments. Previous research has implicated a long and highly complex list of genes in GBM pathogenesis, emphasizing the need for a systemic prioritization that would separate relevant target genes from bystanders and provide detailed knowledge of the complex interactions between multiple disrupted genes and downstream targets.

Dr. Lynda Chin from Dana-Farber Cancer Institute, Dr. Cameron Brennan from Memorial Sloan-Kettering Cancer Center and their colleagues used a high-resolution genome topography scan (GTS) algorithm to both define and rank the patterns of genomic alterations associated with GBM in primary samples and cell lines. Using this new methodology, the researchers discovered an unanticipated co-deletion pattern among closely related INK genes in the GBM oncogenome.

Specifically, the researchers identified a frequent co-deletion of p18INK4C and p16INK4A, a pattern unique to glioblastoma. Functional reconstitution of p18INK4C in GBM cells lacking both p16INK4A and p18INK4C resulted in impaired cell cycle progression and tumorigenic progression. Depletion of p18INK4C in p16INK4A-deficient primary glial cells or established GBM cells enhanced tumorigenicity while acute suppression of p16INK4A in primary glial cells induced an increase in p18INK4C. These results uncover an unanticipated tumor suppressor role for p18INK4C in huma
'/>"/>

Contact: Cathleen Genova
cgenova@cell.com
603-591-8797
Cell Press
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
2. Alsius Corporation Receives Regulatory Approval in China and Mexico
3. InnerPulse, Inc. Appoints Elsa Chi Abruzzo as Vice-President of Regulatory and Quality Affairs
4. CSHL scientists discover new details of a gene-regulatory network governing metabolism
5. Legislative and Regulatory Outlook - 2009 and Beyond for Pharma, Biotech Players
6. Cipher provides CIP-TRAMADOL ER regulatory update
7. Mybank Goes Live With Misys Equation to Support Rapid Growth and Meet Future Regulatory Requirements
8. Mannatech Names New VP of Regulatory Affairs, Quality Assurance
9. Cardiome And Astellas Announce Regulatory Update
10. CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA
11. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...4 CareTech Solutions , an informa... provider for hospitals and health systems, announ...es earned ten awards in the Strategic Communicati...e awards were accepted by CareTech Solutions Execu...Catallo, at the 13th annual Greystone Internet Hea...
(Date:12/4/2009)...an be an effective way to improve moderate to seve... university Karolinska Institutet report. Those wi...ted most from weight loss. , "Our findings sugg... strategy for sleep apnoea in obese men," says Kar...e study. , Sleep apnoea the temporary cessation...
(Date:12/4/2009)... progress has been made over the last 15 years in ... treat epilepsy and its complications. Yet this p...t of the 50 million people around the world, inclu...e United States who have the disorder, , Accordi...American Epilepsy Society (AES), there is an enorm...
(Date:12/4/2009)...hguard (PPM) - certified Dr. Nassery serves local ... and options , Miami Beac...Dr. H.A. Nassery contributes to local athletic com...young athletes and offering the Pure Power Mouthgu...ated Ashley Kimmel, a student at Miami Country Day...
(Date:12/4/2009)...and what 2-D images represent, researchers say , ...eys can recognize photographs of other monkeys the...ces in faces and figure out if they,ve seen them b...ws that capuchin monkeys can decipher the two-dime...hors noted. , The findings, reported by researc...
Breaking Medicine News(10 mins):Health News:CareTech Solutions Web Clients Earn Top Recognition in the Tenth Annual eHealthcare Leadership Awards Competition 2Health News:CareTech Solutions Web Clients Earn Top Recognition in the Tenth Annual eHealthcare Leadership Awards Competition 3Health News:Weight-loss proves effective cure for sleep apnea 2Health News:Weight-loss proves effective cure for sleep apnea 3Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 3Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 4Health News:Miami Dentist Dr. H.A. Nassery Treats Local Teen Golf Star and Helps Improve Her Performance 2
...hed in the medical journal Thorax a study conclude...culosis infection. The study looked at 2,401 adult...frica. The participants were surveyed about their ... Of 1,309 current smokers or ex-smokers, 1,070...
...ug Administration (FDA) issued a public health adv...ers about the suspended marketing of Tysabri (nata...f multiple sclerosis (MS) which was approved by th...ever, it is believed that the drug has a promising...
...hat is often done as a measure for weight reductio...rt disease. One of the most common procedure...urgery that reduces the size of the stomach and al...s to control obesity through lasting weight loss. ...
...ew discovery regarding the cells that are responsi...searchers from Wake Forest University School of Me... the thalamus area of the brain can slow the relea...tective glutamate receptors in increasing their po...
...er Cancer Institute and collaborating institutions... cancer cells where cancer-related genes may lurk....urnal Cancer Research, the researchers used single...nes were either left out or multiplied over and ov...
...cessfully treat atherosclerosis, the narrowing of ...rmine whether the drugs could also treat a similar...rrowing of the aortic valve in the heart. ...osis. For the study researchers from the United Ki...
Other Medicine News:Health News:Possible location of lung cancer genes found 2
(Date:12/4/2009)..., , WILMINGTON, Del., Dec. 4 /PRNewswire-...ounced that the US Food and Drug Administration (F...tiapine fumarate) Extended Release Tablets as adju...ults with Major Depressive Disorder (MDD). SEROQUE...by the FDA to treat both major depressive disorder...
(Date:12/3/2009)..., , ALISO VIEJO, Calif. and STATE COLLEG...SoftGenetics today announced the signing of an agr... services using SoftGenetics, NextGENe software fo... Ambry. ,, (Logo: http://www.newscom.com/cg...sheidt PhD, Ambry,s CSO said, "Our team at Ambry h...
(Date:12/3/2009)..., , SAN DIEGO, Dec. 3 /PRNewswire-FirstCa...nounced today that it has entered into a new lease...GN ) for approximately 131,000 square feet of addi...ace at The Landmark at Eastview campus in Tarrytow...3. This lease of additional space was completed ap...
Breaking Medicine Technology:US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3Helix BioPharma Announces 2413 5 Million Private Placement 13855 1Helix BioPharma Announces 2413 5 Million Private Placement 13855 2Researchers design new graphene based nanomaterial with magnetic properties 13854 1Researchers design new graphene based nanomaterial with magnetic properties 13854 2HCC Life Insurance Company Renames Short Term Medical Insurance 56237 1HCC Life Insurance Company Renames Short Term Medical Insurance 56237 2
...TLE, Dec. 6 Results from RESTORE 2, a,placebo-con...estigational,compound retigabine significantly red... refractory partial-onset epilepsy when a 600 mg o...i-epileptic drug (AED) therapy. Prior to,enrollmen... experiencing,seizures despite taking stable doses...
...ADELPHIA, Dec. 6 GlaxoSmithKline (NYSE: GSK ),a... RAISE (RAndomized placebo-,controlled ITP Study w...,(eltrombopag) in adults with chronic immune (idio...eived one or more prior ITP therapies. Patients,re... those on placebo to,maintain platelet counts betw...
Other Medicine Technology:Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 2Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 3Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 4Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 5GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 2GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 3GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 4GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 5GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 6GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 7GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 8
ABL80 FLEX Blood Gas Analyzer
Paradigm REAL-Time Insulin Pump and Continuous Glucose Monitoring System
IEC CL40R Centrifuge
IEC CL30R Centrifuge
Medicine Products: